GMO Projected Increased US Equity Supply
The firm warned that rising equity issuance could significantly weigh on future stock market returns.
Updated on Sept. 25, 2026 in Investing

Live Poll
Is now a good time for individual investors to be cautious about new stock market listings?
GMO has projected that US equity supply could grow by 5% annually, marking a sharp reversal from the historical 1% annual shrinkage. Analysts warned this surge in new shares could drag down stock returns by 20% over the next 18 months.
Why it matters
The market is struggling to absorb increasing volumes of secondary issuances, massive IPOs, and the unlocking of insider shares. This liquidity pressure may act as a catalyst for a potential collapse of the current AI-driven market bubble.
Companies raised over $137 billion in IPOs during the first half of 2026, representing a 400% increase year-over-year. OpenAI and Anthropic currently account for roughly 5% of the total US investable market cap.
The players
GMO
GMO is a global investment management firm known for its long-term, valuation-based approach to asset allocation.
SpaceX
SpaceX is an aerospace manufacturer and space transportation company that has seen its stock value reach significant levels relative to the broader market.
OpenAI
OpenAI is an artificial intelligence research organization that has become a major component of the current US investable market capitalization.
Anthropic
Anthropic is an AI safety and research company whose equity represents a substantial portion of the broader US market growth.
The details
Investors are currently facing constrained market conditions, where passive and benchmark-aware strategies limit the pool of buyers available for new equity. As corporations increase supply, existing shareholders may be forced to sell current holdings to purchase newly available shares, putting downward pressure on prices.
Timeline
Companies raised $137 billion in public offerings throughout H1 2026.
Stock returns face a projected 20% decline over the next 18 months.
GMO anticipates a significant US equity supply problem over the next several years.
Market Dynamics
This anticipated surge in supply follows the record-setting IPO volume observed in early 2026, signaling a potential shift in market liquidity. As equity issuance accelerates, the environment marks a departure from the historical trend of shrinking stock counts that supported market gains.
Retail investors may see volatility in their 401(k) and brokerage portfolios as the market absorbs these massive new equity offerings. The projected 20% hit to returns suggests that individuals should review their risk tolerance and long-term asset allocation strategies.
The takeaway
Market participants should monitor the pace of new IPOs and secondary offerings as a barometer for potential portfolio headwinds. Diversification remains a critical defense against the systemic risks posed by an oversupply of new equity.
Further reading
For more on market analysis and asset allocation, visit the Investing section.
Live Poll
Is now a good time for individual investors to be cautious about new stock market listings?






